Susquehanna lowered the firm’s price target on Teradyne (TER) to $155 from $165 and keeps a Positive rating on the shares. The firm said they are disappointed with lower 2025 EPS as visibility has been further reduced driven by the current trends in geo politics, though EPS could finally start to exceed $5 in 2026. Susquehanna remains positive on stock given its ong-term EPS opportunity, but also acknowledge it will take some confidence building before the shares could start to reflect that.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TER:
- Teradyne price target lowered to $130 from $155 at UBS
- Teradyne price target lowered to $110 from $125 at Stifel
- Teradyne price target lowered to $140 from $150 at KeyBanc
- Teradyne price target lowered to $85 from $100 at BofA
- Teradyne Positioned for Growth Amid Industry Trends and Strategic Acquisitions